EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Wolfram Beierlein
Vera Becker
Victor Tsang
Martin Elliott
Marc de Leval
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beierlein, W.
Right arrow Articles by van Doorn, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beierlein, W.
Right arrow Articles by van Doorn, C.
Related Collections
Right arrow Valve disease

Eur J Cardiothorac Surg 2007;31:860-865. doi:10.1016/j.ejcts.2007.02.006
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Long-term follow-up after mitral valve replacement in childhood: poor event-free survival in the young child

Wolfram Beierlein, Vera Becker, Robert Yates, Victor Tsang, Martin Elliott, Marc de Leval, Carin van Doorn*

Cardiothoracic Unit, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom

Received 29 November 2006; received in revised form 22 January 2007; accepted 2 February 2007.

* Corresponding author. Address: Great Ormond Street Hospital for Children National Health Service Trust, London WC1N 3JH, United Kingdom. Tel.: +44 207 4059200x5178; fax: +44 207 7626752. (Email: vandoc{at}gosh.nhs.uk).

Objective: In children, mechanical mitral valve replacement may be the only option if the failing mitral valve cannot be repaired. Mandatory anticoagulation and the fixed size prosthesis are of concern in the growing child, but long-term follow-up results are lacking. Methods: Single centre, extended retrospective study of 54 patients who underwent first mitral valve replacement between June 1982 and December 1997. Median age at operation was 3.0 years (range 2 days–18.1 years), 21 patients were ≤ 2.0-year-old. Mitral valve replacement was performed for congenital (43 patients) or acquired (11 patients) heart disease. Median follow-up for operative survivors was 9.2 years, with follow-up > 15 years (maximum 22 years) in nine patients. Results: Thirty-day mortality was 42% in patients ≤ 2-year-old, and 6% in older patients. There were 10 late deaths. Estimated survival at 10 and 15 years follow-up was 33% ± 19% and 33 ± 27% in patients ≤ 2-year-old, and 81% ± 8% and 75% ± 16% in older patients, respectively. High operative mortality in the younger age group was the most important contributor to poor long-term survival. Fifteen patients underwent redo-mitral valve replacement with one operative death. A larger valve was always implanted. Freedom from redo-mitral valve replacement at 10 and 15 years was 25% ± 22% and 0% in patients with prostheses < 23 mm, and 83% ± 13% and 83% ± 27% in patients with larger prostheses. Significant bleeding events occurred in eight patients and were often associated with operative interventions. Estimated freedom from bleeding was 75.7% ± 9% and 70.6% ± 16% at 10 and 15 years, respectively. Thromboembolism and endocarditis were rare. There was no structural valve failure. Estimated freedom from all adverse events at 10 years follow-up was 17% ± 13%. Conclusions: At 10 years follow-up after mechanical mitral valve replacement, most children had suffered an adverse event. At 15 years, all children with a prosthesis < 23 mm had outgrown their valve, but redo-mitral valve replacement with a larger size prosthesis was always possible, and carried low operative risk. Long-term anticoagulation was well tolerated. In children every effort should be made to preserve the native valve.

Key Words: Mitral valve replacement • Child • Long-term follow-up




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
R. Turkoz, C. Ayabakan, C. Vuran, O. Omay, S. V. Yildirim, and N. K. Tokel
Duplicate Mitral Valve in an Infant With Shone's Anomaly.
Ann. Thorac. Surg., November 1, 2009; 88(5): 1683 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Zegdi, B. Amahzoune, M. Ladjali, G. Sleilaty, J. Jouan, C. Latremouille, A. Deloche, and J.-N. Fabiani
Congenital mitral valve regurgitation in adult patients. A rare, often misdiagnosed but repairable, valve disease
Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 751 - 754.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.